The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies
Clinical trial NCT03864185 · COMPLETED
Trial details
- NCT number
- NCT03864185
- Sponsor
- Nagoya University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2021-05-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.